TY - JOUR
T1 - Central venous catheter salvage in ambulatory central line-Associated bloodstream infections
AU - Ford, William J.H.
AU - Bundy, David G.
AU - Oyeku, Suzette
AU - Heo, Moonseong
AU - Saiman, Lisa
AU - Rosenberg, Rebecca E.
AU - DeLaMora, Patricia
AU - Rabin, Barbara
AU - Zachariah, Philip
AU - Mirhaji, Parsa
AU - Klein, Elizabeth
AU - Obaro-Best, Oghale
AU - Drasher, Michael
AU - Peshansky, Alexandre
AU - Rinke, Michael L.
N1 - Publisher Copyright:
Copyright © 2021 by the American Academy of Pediatrics.
PY - 2021/12/1
Y1 - 2021/12/1
N2 - BACKGROUND: Guidelines for treatment of central line-associated bloodstream infection (CLABSI) recommend removing central venous catheters (CVCs) in many cases. Clinicians must balance these recommendations with the difficulty of obtaining alternate access and subjecting patients to additional procedures. In this study, we evaluated CVC salvage in pediatric patients with ambulatory CLABSI and associated risk factors for treatment failure. METHODS: This study was a secondary analysis of 466 ambulatory CLABSIs in patients <22 years old who presented to 5 pediatric medical centers from 2010 to 2015. We defined attempted CVC salvage as a CVC left in place ≥3 days after a positive blood culture result. Salvage failure was removal of the CVC ≥3 days after CLABSI. Successful salvage was treatment of CLABSI without removal of the CVC. Bivariate and multivariable logistic regression analyses were used to test associations between risk factors and attempted and successful salvage. RESULTS: A total of 460 ambulatory CLABSIs were included in our analysis. CVC salvage was attempted in 379 (82.3%) cases. Underlying diagnosis, CVC type, number of lumens, and absence of candidemia were associated with attempted salvage. Salvage was successful in 287 (75.7%) attempted cases. Underlying diagnosis, CVC type, number of lumens, and absence of candidemia were associated with successful salvage. In patients with malignancy, neutropenia within 30 days before CLABSI was significantly associated with both attempted salvage and successful salvage. CONCLUSIONS: CVC salvage was often attempted and was frequently successful in ambulatory pediatric patients presenting with CLABSI.
AB - BACKGROUND: Guidelines for treatment of central line-associated bloodstream infection (CLABSI) recommend removing central venous catheters (CVCs) in many cases. Clinicians must balance these recommendations with the difficulty of obtaining alternate access and subjecting patients to additional procedures. In this study, we evaluated CVC salvage in pediatric patients with ambulatory CLABSI and associated risk factors for treatment failure. METHODS: This study was a secondary analysis of 466 ambulatory CLABSIs in patients <22 years old who presented to 5 pediatric medical centers from 2010 to 2015. We defined attempted CVC salvage as a CVC left in place ≥3 days after a positive blood culture result. Salvage failure was removal of the CVC ≥3 days after CLABSI. Successful salvage was treatment of CLABSI without removal of the CVC. Bivariate and multivariable logistic regression analyses were used to test associations between risk factors and attempted and successful salvage. RESULTS: A total of 460 ambulatory CLABSIs were included in our analysis. CVC salvage was attempted in 379 (82.3%) cases. Underlying diagnosis, CVC type, number of lumens, and absence of candidemia were associated with attempted salvage. Salvage was successful in 287 (75.7%) attempted cases. Underlying diagnosis, CVC type, number of lumens, and absence of candidemia were associated with successful salvage. In patients with malignancy, neutropenia within 30 days before CLABSI was significantly associated with both attempted salvage and successful salvage. CONCLUSIONS: CVC salvage was often attempted and was frequently successful in ambulatory pediatric patients presenting with CLABSI.
UR - http://www.scopus.com/inward/record.url?scp=85122490106&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85122490106&partnerID=8YFLogxK
U2 - 10.1542/peds.2020-042069
DO - 10.1542/peds.2020-042069
M3 - Article
C2 - 34814175
AN - SCOPUS:85122490106
SN - 0031-4005
VL - 148
JO - Pediatrics
JF - Pediatrics
IS - 6
M1 - e2020042069
ER -